{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:10:01Z","timestamp":1792408201562,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1716,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/modpathol.2017.186","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T07:40:36Z","timestamp":1515742836000},"page":"732-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration"],"prefix":"10.1016","volume":"31","author":[{"given":"Grzegorz","family":"Rymkiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Grygalewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Chechlinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Blachnio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Bystydzienski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Romejko-Jarosinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Woroniecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michalina","family":"Zajdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Domanska-Czyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Martin-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Nadeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Swoboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Rygier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pienkowska-Grela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Konrad","family":"Siwicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Prochorec-Sobieszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Salaverria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Walewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2017.186_bib1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s12032-010-9614-0","article-title":"Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement","volume":"28","author":"Pienkowska-Grela","year":"2011","journal-title":"Med Oncol"},{"key":"10.1038\/modpathol.2017.186_bib2","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","article-title":"A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma","volume":"123","author":"Salaverria","year":"2014","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.186_bib3","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.3324\/haematol.2015.124305","article-title":"Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain\/loss pattern","volume":"100","author":"Ferreiro","year":"2015","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2017.186_bib4","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1007\/s13277-015-3203-y","article-title":"miR expression in MYC-negative DLBCL\/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma","volume":"36","author":"Zajdel","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1038\/modpathol.2017.186_bib5","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.186_bib6","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"262","author":"Leoncini","year":"2008"},{"key":"10.1038\/modpathol.2017.186_bib7","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2017.186_bib8","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2017.186_bib9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/PAS.0000000000000839","article-title":"LMO2-negative expression predicts the presence of MYC translocations in aggressive B-cell lymphomas","volume":"41","author":"Colomo","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.186_bib10","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1182\/blood-2008-03-145128","article-title":"A prospective clinicopathologic study of dose-modified CODOX-M\/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC\/NCRI LY10 trial)","volume":"112","author":"Mead","year":"2008","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.186_bib11","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1182\/blood-2014-03-563627","article-title":"Improved outcome of adult Burkitt lymphoma\/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial","volume":"124","author":"Hoelzer","year":"2014","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.186_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1309\/AJCPATRQWANW2O3N","article-title":"Cytogenetic and flow cytometry evaluation of Richter syndrome reveals MYC, CDKN2A, IGH alterations with loss of CD52, CD62L and increase of CD71 antigen expression as the most frequent recurrent abnormalities","volume":"143","author":"Woroniecka","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.186_bib13","unstructured":"ISCN 2016 An International System for Human Cytogenomic Nomenclature (2016). Karger: Basel: Switzerland, 2016."},{"key":"10.1038\/modpathol.2017.186_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13039-015-0212-x","article-title":"Monoallelic and biallelic deletions of 13q14 in a group of CLL\/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K)","volume":"9","author":"Grygalewicz","year":"2016","journal-title":"Mol Cytogenet"},{"key":"10.1038\/modpathol.2017.186_bib15","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1080\/10428190902930470","article-title":"Bright CD38 expression is an indicator of MYC rearrangement","volume":"50","author":"Maleki","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/modpathol.2017.186_bib16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/modpathol.2010.76","article-title":"Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas","volume":"23","author":"Seegmiller","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2017.186_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/PAS.0b013e3180959e09","article-title":"Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation","volume":"32","author":"Rodig","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.186_bib18","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood.V126.23.2679.2679","article-title":"Significance of a critical set of 11q chromosome aberrations for diagnosis of MYC negative Burkitt lymphoma","volume":"126","author":"Rymkiewicz","year":"2015","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.186_bib19","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1182\/blood.V95.6.1900","article-title":"Cell adhesion receptors in lymphoma dissemination","volume":"95","author":"Drillenburg","year":"2000","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.186_bib20","series-title":"Recommendations of the European Working Group for Adult ALL","first-page":"29","article-title":"Burkitt lymphoma and leukemia. Patients without HIV infection. In: Recommendations of the European Working Group for Adult ALL","author":"Walewski","year":"2011"},{"key":"10.1038\/modpathol.2017.186_bib21","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1309\/C1PP15P7CDB8UY39","article-title":"Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation","volume":"128","author":"Sevilla","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.186_bib22","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood.V124.21.1640.1640","article-title":"Flow cytometry and cytogenetics of fine needle aspiration biopsy samples is a reliable method for diagnosing Burkitt lymphoma. Evaluation of 78 cases from a single-institution","volume":"124","author":"Rymkiewicz","year":"2014","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.186_bib23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1038\/modpathol.2017.186_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/01.pai.0000208279.66189.43","article-title":"CD56-positive large B-cell lymphoma","volume":"14","author":"Weisberger","year":"2006","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2017.186_bib25","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3324\/haematol.2010.026831","article-title":"Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis","volume":"95","author":"Scholtysik","year":"2010","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2017.186_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/X8LBRRBBC43PL9HC","article-title":"The usefulness of CD71 expression by flow cytometry for differentiating indolent from aggressive CD10+ B-cell lymphomas","volume":"126","author":"Wu","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.186_bib27","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1182\/blood.V128.22.1754.1754","article-title":"DA-EPOCH-R is an effective regimen in high grade B-cell lymphoma defined by cell-of-origin, karyotype and BCL2\/MYC\/BCL6 status and expression","volume":"128","author":"Rymkiewicz","year":"2016","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.186_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/PAS.0000000000000365","article-title":"Expression profiles of MYC protein and MYC gene rearrangement in lymphomas","volume":"39","author":"Chisholm","year":"2015","journal-title":"Am J Surg Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2017186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2017186","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522201506X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522201506X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/modpathol.2017.186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2017186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:49:30Z","timestamp":1760230170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522201506X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S089339522201506X"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2017.186","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2017.186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}